Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Propranolol is effective and safe for treating infantile hemangioma, but more research is needed for dosing and monitoring guidelines.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Hsc70 protein may influence hair growth by responding to androgens.

COVID-19 doesn't make alopecia areata worse.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

Sebaceous glands are involved in various skin disorders, some treatable with medications like finasteride and minoxidil.

Some thymic peptides can increase human hair growth, while others may inhibit it.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

Skin stem cells remember past inflammation, helping them respond better to future injuries and possibly aiding in treating skin issues.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Taking a probiotic supplement twice a day improved hair growth, skin hydration, and metabolic health in adults at risk of metabolic syndrome.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

A specific enzyme is essential for proper hair follicle stem cell development and healthy skin.

Oxidative stress is linked to mild patchy alopecia areata.

Continuous research and innovative strategies are essential for sustainable development.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Certain genes influence immunoglobulin levels in Chinese Holstein cows, which can improve calf health.

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Men with both baldness and scalp psoriasis often don't have psoriasis on bald spots.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.